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Abstract
Background: Benign ectopia of prostatic glandular tissue in the seminal vesicles is rare with only three prior cases
reported in the literature. Prostate cancer, arising within prostatic ectopia in the seminal vesicles, has never been
described and therefore presents a challenge in both diagnosis and management.
Case presentation: Herein, we report a rare case of prostatic adenocarcinoma in ectopic prostate tissue in
the left seminal vesicle, without evidence of prostatic glandular involvement. This case was diagnosed on
multi-parametric magnetic resonance imaging and confirmed with magnetic resonance imaging-transrectal
ultrasound fusion biopsy.
Conclusions: Awareness of this unusual phenomenon is significant because of the potential occurrence of
malignancy to arise in unexpected, extra-glandular locations, which are not routinely sampled on routine
transrectal ultrasound biopsy. However attention to lesions with characteristic multi-parametric magnetic
resonance imaging features of prostate cancer, regardless of extra-glandular location, will help direct tissue
sampling, facilitate a timely diagnosis and ensure appropriate management.
Background
An 80 year-old male, with a past medical history of
benign prostatic hyperplasia (BPH), presented to Urology
with a rising serum prostate specific antigen (PSA)
level of 13.1 ng/mL. In 2008 and again in 2012, the
patient underwent two 12-core TRUS biopsies, which
yielded negative results. Given his rising PSA level,
the patient subsequently underwent diagnostic multi-
parametric prostate MR imaging to localize any po-
tentially malignant lesions that may have been missed
on biopsies.
Case presentation
Multi-parametric prostate MR imaging revealed no abnor-
mality in the central, transitional or peripheral zones of
the prostate gland. However, in the left seminal vesicle
and non-contiguous with the adjacent prostate gland or
capsule, there was an abnormal 1.5 × 1.2 × 1.0 cm lesion
with conspicuous hypointense T2-weighted (T2W) signal
intensity seen on high-resolution axial imaging (Fig. 1a).
High-resolution coronal and sagittal T2W images show,
to advantage, this lesion within the left seminal vesicle
(Fig. 1b-c), external to the prostate gland capsule, which is
maintained with normal signal intensity and morphology.
No T2W signal intensity abnormality is seen in the
adjacent left prostate gland base related to the left seminal
vesicular abnormality. Moreover, there is no exophytic
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hyperplastic nodule or contiguous extension of prostatic
glandular tissue related to the abnormality in the left
seminal vesicle. On high b-value diffusion weighted im-
aging (DWI) and apparent diffusion coefficient (ADC)
map, this lesion features significantly diminished diffu-
sivity with low ADC mean value of 0.5 × 10−3 mm2/s
(Fig. 1d-e). There is no abnormal diffusivity in the
adjacent or regional left prostate gland base peripheral
or transitional zone related to the left seminal vesicular
abnormality. Pre- and post-contrast fat-saturated T1-
weighted (T1W) imaging obtained prior to and follow-
ing the infusion of intravenous gadolinium contrast
show abnormal perfusion of this lesion (Fig. 2a-b).
Abnormal perfusion pattern of this lesion is confirmed
with CAD, which demonstrates early enhancement with
partial washout and colorimetric stratification of ‘green’
and ‘red’: indeterminate/suspicious (‘green’) and highly
suspicious (‘red’) (Fig. 2c dashed arrow and solid arrow).
The hyperperfused lesion in the left central zone with
highly suspicious enhancement (Fig. 2c asterisk) demon-
strated relative hypointensity on T2W imaging with thin,
circumscribed hypointense periphery, and no diminished
diffusivity, compatible with a hyperplastic (BPH) stromal
nodule that was later confirmed on MR imaging-TRUS
fusion biopsy with no malignancy on tissue histopatho-
logical sampling. This lesion was reported as clinically
significant cancer is highly likely to be present; it was sub-
sequently targeted on MR imaging-TRUS software-based
fusion biopsy. Repeat 14-core TRUS biopsy, supplemented
with targeted MR imaging-ultrasound fusion-guidance,
was performed of the prostate gland and left seminal
vesicle. Ultrasound gray-scale imaging from the fusion
biopsy confirms an abnormal hypoechoic lesion in the left
seminal vesicle (Fig. 3).
Tissue histology from the repeat 14-core biopsies
revealed benign prostatic tissue in all prostate gland
sextants (12 cores), particularly in the left prostate base
(3 total cores). However core biopsies of the lesion in
Fig. 1 Multi-parametric magnetic resonance (MR) imaging of the prostate gland demonstrates normal prostate gland however an abnormal lesion in
the left seminal vesicle features classical imaging features of prostate carcinoma. a High-resolution axial T2-weighted (T2W) image demonstrates an
abnormal 1.5 × 1.2 × 1.0 cm lesion with relative hypointensity (arrow) subjacent to an enlarged prostate gland (arrowhead). The capsule is maintained
without trans-capsular extension. b–c High-resolution multi-planar T2W images in the sagittal and coronal planes show, to advantage, this lesion within
the left seminal vesicle (arrow), external to the capsule of the prostate gland (arrowhead). No T2W signal intensity abnormality is in the adjacent left
prostate gland base peripheral or transitional zone. Moreover, there is no exophytic hyperplastic nodule or contiguous extension of prostatic glandular
tissue related to the abnormality in the left seminal vesicle. Normal right seminal vesicle denoted for comparison (asterisk). d High b-value diffusion
weighted imaging (DWI) shows that this lesion demonstrates significantly diminished diffusivity (arrow). e Apparent diffusion coefficient (ADC) map
confirms significantly diminished diffusivity in this lesion (arrow) with low ADC mean value of 0.5 × 10−3 mm2/s (region of interest). No diminished
diffusivity was seen in the prostate gland (arrowhead)
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the left seminal vesicle revealed both malignant and
benign prostatic tissue.
Fusion-guided targeted core biopsy of the left seminal
vesicular lesion demonstrated prostate adenocarcinoma
with a predominant Gleason four pattern, characterized
by collections of neoplastic cells with minimal gland
formation, surrounded by benign prostatic glandular
elements within benign seminal vesicular tissue (Fig. 4a).
A secondary Gleason three pattern is identified with
recognizable neoplastic glands (Fig. 4b). The carcinoma
involves approximately 60 % of the submitted core bi-
opsy fragments (Fig. 5). The presence of benign pros-
tatic glandular elements in seminal vesicular tissues
is abnormal, confirming the presence of prostatic
ectopia. Moreover, alpha-methylacyl-CoA racemase over-
expression confirms the presence of prostate carcinoma.
Multiple fusion-guided targeted biopsies of the adjacent
left prostate gland base peripheral and transition zones
revealed only benign prostatic tissue with no malig-
nancy. Following complete diagnostic workup, staging,
and multi-disciplinary discussion of therapeutic options
with the Departments of Urology, Radiation Oncology,
and Pathology, the patient was treated as stage III
disease (T3bN0M0) and underwent external beam radi-
ation therapy (EBRT) and hormonal therapy.
While the phenomenon of ectopic prostatic glandular
tissue in the genitourinary tract is rare, it is not entirely
uncommon. While the majority of cases of benign pros-
tatic ectopia have been reported in the urinary bladder
[1, 2] and urethra [3], cases have also been described in
the retro-vesicular space [4, 5], seminal vesicles [6–8],
epididymis [9], testis [10], and rectum [11]. Cancer
arising in prostatic ectopia has only been reported
four times in the literature, all in the urinary bladder
and urethra [12–15]. However we report a case of
primary prostate adenocarcinoma arising in the seminal
vesicle, without glandular or trans-capsular involvement,
which to our knowledge, has never been described.
Conclusions
Due to its infrequency, malignancy arising within prostatic
ectopia in the seminal vesicles has never been described
and therefore presents a challenge in both diagnosis and
management. Awareness of this unusual phenomenon is
Fig. 3 Gray-scale ultrasound image from MR imaging-TRUS fusion
biopsy demonstrates the abnormal, hypoechoic lesion in the left
seminal vesicle (arrow); normal right seminal vesicle for comparison
(asterisk) and prostate gland (cross-hairs)
Fig. 2 a-b Pre- and post-contrast fat-saturated T1-weighted (T1W) imaging of the prostate gland (arrowhead) and left seminal vesicle (arrow)
reveal that this lesion demonstrated abnormal perfusion on dynamic contrast enhancement (DCE). c Computer-aided detection (CAD) confirms
abnormal perfusion pattern of the lesion in the left seminal vesicle, which demonstrates early enhancement with partial washout and colorimetric
stratification of both indeterminate/suspicious (‘green’) (dashed arrow) and highly suspicious patterns (‘red’) (solid arrow). The hyperperfused lesion
in the left central zone with highly suspicious enhancement on CAD (asterisk) demonstrated relative hypointensity on T2W imaging with thin,
circumscribed hypointense periphery, and no diminished diffusivity, compatible with a hyperplastic (BPH) stromal nodule that was later confirmed
as benign on MR imaging-TRUS fusion biopsy
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significant because of the potential occurrence of malig-
nancy to arise in unexpected, extra-glandular locations,
which are not routinely sampled on routine transrectal
ultrasound biopsy. However attention to lesions with
characteristic multi-parametric magnetic resonance im-
aging features of prostate cancer, regardless of extra-
glandular location, will help direct tissue sampling,
facilitate a timely diagnosis and ensure appropriate
management.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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Fig. 5 Prostate adenocarcinoma, predominant Gleason 4 pattern
and secondary Gleason 3 pattern (Gleason 4 + 3 = 7), H&E stain
image, 400× magnification
Fig. 4 a Photomicrographs from tissue histopathological examination reveals prostate adenocarcinoma, Gleason 4 pattern (left of image),
characterized by collections of neoplastic cells with minimal gland formation, with benign prostatic glandular elements and seminal vesicular
tissue (right of image), H&E stain image, 10× magnification. b Prostate adenocarcinoma, predominant Gleason 4 pattern and secondary Gleason 3
pattern, H&E stain image, 10× magnification. The carcinoma involves approximately 60 % of the submitted core biopsy fragments
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